The resolution and the amendments of Lyme Europe disease which were unanimously voted and adopted in ENVI committee on September 10, 2018.

In October she goes to the vote in plenary session.

further to Question for Oral Answer B8-0000/2018 pursuant to Rule 128(5) of the Rules of Procedure on Lyme Disease (Borreliosis) (2018/0000(RSP))

Alojz Peterle
Daciana Octavia Sârbu
Jadwiga Wiśniewska
Frédérique Ries
Merja Kyllönen
Michèle Rivasi
Mireille D’Ornano
Sylvie Goddyn

on behalf of the Committee on the Environment, Public Health and Food Safety B8-0000/2018

European Parliament resolution on Lyme Disease (Borreliosis) (2018/0000(RSP))

The European Parliament,

– having regard to the question to the Commission on Lyme Disease (Borreliosis) (O-000000/2018 – B8-0000/2018),

– having regard to the motion for a resolution of the Committee on the Environment, Public Health and Food Safety,

– having regard to Rules 128(5) and 123(2) of its Rules of Procedure,

– having regard to the report related to the systematic literature review on the diagnostic accuracy of serological tests for Lyme borreliosis of the European Centre for Disease Prevention and Control,

– having regard to the Expert Network consultation meeting on Lyme borreliosis surveillance in the European Union, in January 2016 in Stockholm,

– having regard the Decision No 2119/98/EC of the European Parliament and of the Council of 24 September 1998 setting up a network for the epidemiological surveillance and control of communicable diseases in the Community,

Amendment

Mireille D’Ornano
– having regard to Article 168(7) of the Treaty on the Functioning of the European Union, under which responsibility for the organisation and delivery of health services and medical care lies with the Member States;

———————————————-

A. whereas the right to health is a fundamental right recognised by the European Treaties, in particular in its Article 168;

Amendment

Claudiu Ciprian Tănăsescu

Aa. whereas Lyme disease (Borreliosis) is an infectious disease in humans and in various species of domestic and wild animals transmitted by ticks;

———————————————

B whereas Lyme disease, or Lyme borreliosis, is a bacterial disease caused by the bacterium Borrelia burgdorferi, and is transmitted to humans by the vector of a tick bite, itself contaminated by the bacterium;

———————————————–

C. whereas Lyme borreoliosis is the most common zoonotic disease in Europe with 650 – 850.000 estimated cases with a higher incidence in Central Europe;

Amendment

Urszula Krupa

C. whereas Lyme borreoliosis is the most common zoonotic disease in Europe with 650-850.000 estimated cases with a higher incidence in Central Europe; whereas infection occurs in the spring-summer semester (IV-X), and borreoliosis is recognised in those countries as an occupational disease for farmers, forestry workers and field researchers;

———————————————–

D. whereas infected ticks and the disease seem to be expanding geographically, also in higher altitudes and latitudes; suspected to be caused by, among other things, changes in land use, climate change, and other activities related to human behaviour;

Amendments

Urszula Krupa

D. whereas infected ticks and the disease seem to be expanding geographically, also in higher altitudes and latitudes, as well as in towns and cities; whereas this is suspected to be caused by, among other things, changes in land use, inter alia through the afforestation of land of the lowest quality or through the expansion of invasive plants, climate change, and other activities related to human behaviour;

Claudiu Ciprian Tănăsescu

D. whereas infected ticks and the disease seem to be expanding geographically, also in higher altitudes and latitudes; suspected to be caused by, among other things, changes in land use, climate change, global warming, excessive humidity and other activities related to human behaviour;

———————————————–

E. whereas there is no European consensus on Lyme disease treatment, diagnosis and screening and national practices vary;

———————————————–

F. whereas the bite by an infected tick and the symptoms of Lyme disease can go unnoticed or even be in some cases asymptomatic, leading to sometimes severe complications and permanent damage similar to a chronic disease, in particular when the patient is not promptly diagnosed;

———————————————–

G. whereas more reliable early diagnosis of Lyme disease will reduce the number of later stage cases significantly, improving the quality of life of patients, and whereas it will reduce the financial burden of the disease, saving approximately € 330 million on healthcare costs in the first 5 years already according to managers of DualDur EU research project;

———————————————–

H. whereas many patients do not have access to the treatments that would suit them, nor are promptly diagnosed; whereas they feel deprived and unheard of public authorities and that some of them continue to have persistent symptoms that can lead to chronic disease;

———————————————–

I. whereas there is currently no vaccine available for Lyme disease;

———————————————–

J. whereas the burden of Lyme borreliosis in the EU is unknown due to the lack of statistics of this disease and heterogeneity of applied case definitions and surveillance systems;

Amendment

Claudiu Ciprian Tănăsescu

J. whereas the burden of Lyme borreliosis in the EU is unknown due to the lack of statistics of this disease and heterogeneity of applied case definitions, laboratory methods used and surveillance systems;

———————————————–

K. whereas there is no ICD code separation of the early states and late state Lyme disease; whereas there are no individual ICD codes for the different late state Lyme disease symptoms;

———————————————-

L. whereas the treatment practice guidelines of ILADS (International Lyme and Associated Diseases Society) and of IDSA (Infectious Diseases Society of America) differ and the differences between the two approaches to the disease also impact treatment practices in the EU;

———————————————–

M. whereas there is a lack of profound understanding of the mechanism which turns Lyme disease into a chronic disease;

———————————————–

N. whereas facing this health issue, health professionals have sounded the alarm for nearly a decade, as have patients’ associations and whistle-blowers;

—————————————————

O. whereas Lyme disease, although well known in medical science, is still underdiagnosed, in particular because of the difficulties existing in the detection of symptoms;

Amendment

Urszula Krupa

O. whereas Lyme disease, although well known in medical science, is still underdiagnosed, in particular because of the difficulties existing in the detection of symptoms and the absence of appropriate diagnostic tests;

————————————————–

P. whereas the screening tests used for Lyme Disease are not always able to provide accurate results, such as the Elisa test which only detects one infection at a time;

Amendement

Urszula Krupa

P a. whereas many Europeans are continuously exposed to Lyme borreoliosis through their profession (farmers, forestry workers, researchers and students carrying out field research – e.g. biologists, geologists, surveyors and archaeologists, etc.);

————————————————–

Q. whereas the medical profession often follows outdated recommendations on Lyme Disease that do not take sufficiently into account the evolution of research;

————————————————–

1. Expresses its concern at the spread of Lyme disease in the European population in alarming proportions, since around 1 million citizens suffer from the disease according to the census methods used;

————————————————–

2. Recalls that all Member States, to varying degrees, are experiencing an upsurge in Lyme Borreliosis, making it a European health problem of its own;

————————————————–

3. Welcomes the funding allocated until to now by the Union for the search for early detection and future treatment of Lyme borreliosis (up to 16 million euros through projects such as ANTIDotE, ID-LYME and LYMEDIADEX);

————————————————-

4. Calls for additional funding on the methods for diagnosing and treating Lyme disease; Encourages, to that end, to foster the research efforts, both in terms of increased funds allocated and of exchange of epidemiological data, including data on distribution and prevalence of pathogenic and non-pathogenic genospecies;

————————————————–

5. Calls for additional international cooperation on the research on Lyme disease;

————————————————–

6. Encourages the Commission to collect the largest number of information on the screening methods or on treatments administered in the Member States;

Amendments

Claudiu Ciprian Tănăsescu

6. Encourages the Commission to collect the largest number of information on Lyme disease screening methods or on treatments administered in the Member States;

Claudiu Ciprian Tănăsescu

6a. Calls for mandatory reporting in all Member States affected by Lyme disease;

————————————————–

7. Calls on the Commission to facilitate cooperation and exchange of best practices among Member States in terms of monitoring, diagnosis and treatment of Lyme disease;

Amendment

Claudiu Ciprian Tănăsescu

7a. Welcomes the inclusion by certain Member States of Lyme disease in their national surveillance system based on a specific methodology;

————————————————–

8. Calls on the Commission to put in place uniform surveillance programmes and work together with the Member States to facilitate the standardisation of diagnosis tests and treatments;

Amendments

Urszula Krupa

8. Calls on the Commission to put in place uniform surveillance programmes and work together with the Member States to facilitate the standardisation of diagnosis tests and treatments; calls on the Commission to recognise borreoliosis as an occupational disease for agricultural and forestry workers, as well as for field scientists (e.g. biologists, geologists, surveyors and archaeologists, etc.);

Claudiu Ciprian Tănăsescu

8a. Calls for individual tick prevention and control measures in the Member States to contain the spread of the Borrelia bacteria;

————————————————–

9. Calls for the development of evidence-based guidance on clinical and laboratory diagnosis of Lyme borreliosis; calls for the ICD code separation of the early states and late state Lyme disease; calls also for individual ICD codes for the different late state Lyme disease symptoms;

————————————————–

10. Requests that the Commission publishes guidelines, based on the best practices within the EU, with regard to the training of general practitioners to facilitate the diagnosis and screening of Lyme disease;

——————————————–

11. Asks Member States to expand the use of clinical examination so that doctor can diagnose Lyme disease even if the serology tests are negative, in order to help patients break the “therapeutic deadlock”;

——————————————–

12. Calls on the Commission to assess the magnitude of the phenomenon of patients looking for appropriate diagnosis and treatment for a long time which some patients face, and in particular the transboundary movements of patients seeking treatment and financial consequences thereof;

Amendment

Claudiu Ciprian Tănăsescu

12. Calls on the Commission to assess the magnitude of the phenomenon of patients looking for appropriate diagnosis and treatment of Lyme disease for a long time which some patients face, and in particular the transboundary movements of patients seeking treatment and financial consequences thereof;

——————————————–

13. Urges the planning and creation of innovative projects that can contribute to improved data gathering and greater effectiveness of awareness raising activities;

Amendments

Urszula Krupa

13. Urges the planning and creation of innovative projects that can contribute to improved data gathering and greater effectiveness of education and awareness raising activities;

Daciana Octavia Sârbu, Nicola Caputo

13 a. Welcomes the European Commission implementing decision on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant definitions, that includes the Lyme neuroborreliosis in the communicable diseases list.

——————————————–

14. Urges Member States to facilitate the inclusion of Lyme disease in the European list of communicable diseases as it meets the selection criteria set out in the Annex to Decision 1082/2013 / EU;

——————————————–

15. Emphasises that the addition of Lyme disease to the European epidemiological surveillance network will enable patients to benefit from the advantages of a robust and structured health system: permanent communication between competent national authorities, rapid and reliable identification of cases of Borreliosis Lyme in the Union, mutual assistance in the field of analysis and interpretation of surveillance data collected and deployment of devices necessary to stop its spread in humans;

Amendment

Daciana Octavia Sârbu

15. Emphasises that the addition of Lyme disease to the European epidemiological surveillance network is enabling patients to benefit from the advantages of a robust and structured health system: permanent communication between competent national authorities, rapid and reliable identification of cases of Borreliosis Lyme in the Union, mutual assistance in the field of analysis and interpretation of surveillance data collected and deployment of devices necessary to stop its spread in humans;

——————————————–

16. Invites the Member States, which will be able to rely on the Commission’s logistical support, to set up an awareness campaign on the disease, first and foremost in the regions most affected by its spread;

Amendment

Claudiu Ciprian Tănăsescu

16. Invites the Member States, which will be able to rely on the Commission’s logistical support, to set up an information and awareness campaign to alert the population and all those concerned to the existence of Lyme disease, first and foremost in the regions most affected by its spread;

——————————————–

17. Calls on the Commission to draw up a European plan to combat Lyme disease commensurate with the seriousness of this silent epidemic encourages the set-up of a European network on Lyme Disease including relevant stakeholders;

——————————————-

18. Calls on the Commission and the Member States to publish common prevention guidelines for those who have a high risk of getting Lyme Disease, such as outdoors workers, and standardised diagnostic and treatment guidelines.

Amendment

Urszula Krupa

18a. Calls on the Commission to introduce preventive tests and a method for rapidly treating and monitoring the course of Lyme borreoliosis infections among professionals in the agroforestry sector and scientists involved in gathering field data;

——————————————

19. Instructs its President to forward this resolution to the Commission.